First-in-human phase 1 trial of hemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative

Blood Adv. 2022 Nov 8;6(21):5711-5715. doi: 10.1182/bloodadvances.2022007977.
No abstract available

Publication types

  • Clinical Trial, Phase I
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Substitutes* / adverse effects
  • Blood Transfusion
  • Erythrocytes
  • Hemoglobins
  • Humans

Substances

  • Blood Substitutes
  • Hemoglobins